Literature DB >> 11575588

Depression in multiple sclerosis: relationship to planning ability.

P A Arnett1, C I Higginson, J J Randolph.   

Abstract

Recent research has demonstrated deficits on effortful executive tasks involving planning in multiple sclerosis (MS) patients. Given the high prevalence of depression in MS and the commonly reported link between depression and performance on executive tasks, planning impairments in MS may be associated with depression. We compared the performance of depressed and nondepressed MS patients on a planning task (Tower of London-TOL) to evaluate this hypothesis. Compared with nondepressed MS patients, depressed MS patients made significantly (p < .05) more moves and took more time per trial on the TOL. A follow-up regression analysis was conducted that included the TOL and speeded attentional/working memory task indices found to be associated with depression in MS from the authors' prior reports. This analysis revealed that 25% of the variance in depression scores was predicted by the most sensitive speeded attentional/working memory task. Furthermore, this variance overlapped completely with variance predicted by the TOL-time/trial index. The only clearly nonspeeded task index, TOL-moves per trial, was associated with unique variance (8%) in predicting MS depression scores. These results suggest that slowed information processing speed and, secondarily, deficient nonspeeded central executive skill, may be core to the cognitive deficits characteristic of depressed MS patients.

Entities:  

Mesh:

Year:  2001        PMID: 11575588     DOI: 10.1017/s1355617701766027

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  17 in total

1.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

2.  Relationship between expanded health belief model variables and mammography screening adherence in women with multiple sclerosis: a pilot study.

Authors:  Karen Paraska
Journal:  Int J MS Care       Date:  2012

Review 3.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

Review 4.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 5.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

6.  Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.

Authors:  Sarah W Kinsinger; Emily Lattie; David C Mohr
Journal:  Neuropsychology       Date:  2010-09       Impact factor: 3.295

7.  Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis.

Authors:  Gabriela Magalhães Pereira; Jefferson Becker; Nayron Medeiros Soares; Lucas Araújo de Azeredo; Rodrigo Grassi-Oliveira; Andreo Rysdyk; Rosa Maria Martins de Almeida
Journal:  J Neural Transm (Vienna)       Date:  2019-06-27       Impact factor: 3.575

Review 8.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

Review 9.  Measurement and maintenance of reserve in multiple sclerosis.

Authors:  Brian M Sandroff; Carolyn E Schwartz; John DeLuca
Journal:  J Neurol       Date:  2016-04-12       Impact factor: 4.849

10.  Preserved decision making ability in early multiple sclerosis.

Authors:  S Simioni; C Ruffieux; J Kleeberg; L Bruggimann; J-M Annoni; M Schluep
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.